Business · 12/06/2020
FDA Extends Comment Period for Draft Guidance on Compounding Animal Drugs
The FDA is extending the comment period for its draft guidance on compounding animal drugs from bulk drug substances, in response to requests for an extension, to allow interested persons more time to submit comments.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →